HLB Co., Ltd. (KOSDAQ:028300)

South Korea · Delayed Price · Currency is KRW

56,800

+900 (1.61%)

Apr 10, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biomedical Device Business Sector			18.51B	161.43B	44.05B	13.86B	8.65B
Biomedical Device Business Sector Growth			-88.53%	266.45%	217.82%	60.33%	-2.01%
Venture Investment			1.66B	11.24M	-	-	-
Venture Investment Growth			14691.04%	-	-	-	-
Composite Material Business Sector			23.54B	19.00B	25.77B	42.32B	29.78B
Composite Material Business Sector Growth			23.89%	-26.29%	-39.09%	42.12%	8.82%
Cross-Segment Profits			-810.90M	-730.22M	-	-	-
Total			42.90B	179.71B	69.83B	56.18B	38.42B
Total Growth			-76.13%	157.37%	24.30%	46.22%	6.18%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Overseas			-	-	26.54B	25.70B	21.01B
Overseas Growth			-	-	3.24%	22.33%	56.22%
South Korea			39.78B	179.34B	43.29B	30.47B	17.41B
South Korea Growth			-77.82%	314.29%	42.06%	75.05%	-23.43%
China			1.78B	1.10B	-	-	-
China Growth			62.70%	-	-	-	-
USA			1.34B	-	-	-	-
Unallocated			-	-730.22M	-	-	-
Total			42.90B	179.71B	69.83B	56.18B	38.42B
Total Growth			-76.13%	157.37%	24.30%	46.22%	6.18%

Source: S&P Global Market Intelligence.